Skip to main content
. 2021 Sep 6;11:754146. doi: 10.3389/fonc.2021.754146

Figure 5.

Figure 5

Circ_0013587 mediates erlotinib resistance through regulating miR-1227 expression. (A, B) AsPC-1/Erlo (A) and AsPC-1 (B) cells transfected as indicated were exposed to each concentration of erlotinib for 48 h, and the inhibitory effects of erlotinib were evaluated using CCK-8 assays. (C, D) Pancreatic cancer cells were transfected as indicated and cell invasion was measured using transwell invasion assays. ***P < 0.001.